Vontobel Holding
GILD icon

Vontobel Holding’s Gilead Sciences GILD Stock Holding History

Vontobel Holding’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-150,000
Closed -$10.2M – 1036
2020
Q4 		$10.2M Buy
+150,000
New +$9.05M 0.07% 172

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vontobel Holding's GILD Position: Q2 2026 in Review

Vontobel Holding increased its Gilead Sciences (GILD) stake by 4.6% in Q2 2026, buying an estimated $5.46M and bringing the position to 947,749 shares worth $120M. The position accounts for 0.38% of the portfolio, ranked #69.

Vontobel Holding first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $126M in Q1 2026. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vontobel Holding held 947,749 shares of Gilead Sciences worth $120M as of Q2 2026.
  • Vontobel Holding bought 41,454 Gilead Sciences shares in Q2 2026, an estimated $5.46M.
  • Gilead Sciences made up 0.38% of Vontobel Holding's portfolio in Q2 2026, its #69 holding.
  • Vontobel Holding first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Gilead Sciences position peaked at $126M in Q1 2026.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.